UNSPSC 51183100: Antidiabetic and hyperglycemic amides

This classification organic compounds containing the -CO-NH2 radical, substances called amides, that lower blood glucose levels, substances generally classed as antidiabetics or hyperglycemics, thus the term ANTIDIABETIC AND HYPERGLYCEMIC AMIDES.

UNSPSC 51183100 Antidiabetic and hyperglycemic amides, a Class code, covers pharmaceutical compounds used to manage diabetes and hyperglycemia in state and local health systems, correctional facilities, and public health programs. The code encompasses synthetic amide-class drugs such as sulfonylureas and related agents that stimulate insulin secretion or improve glucose metabolism. State and local buyers under this code include state health departments, county health systems, municipal hospitals, correctional departments, and public health clinics that procure these medications through standing contracts, group purchasing organizations, and competitive bid cycles. Purchasing patterns reflect both routine maintenance of chronic-disease formularies and episodic restocking tied to patient volume and clinical protocol updates.

The source provided contains no recent state and local contract opportunities tagged to this code. Without posted solicitations in the <most-recent-state-local-contract-opportunities> block, the current geographic distribution, issuing-body concentration, and representative procurement activity cannot be characterized from available data. Firms seeking to pursue this code should monitor state health department pharmaceutical RFQs, county hospital ITBs, and cooperative purchasing vehicle awards in their target regions, as pharmaceutical procurement under UNSPSC 51183100 typically follows established group contracting vehicles and state health system formulary cycles rather than frequent one-off solicitations.